Search - tctmd.com

Displaying 221 - 240 of 285

Sort: Relevancy | Date

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Daily News

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

L.A. McKeown

February 07, 2016

News Daily News

Delirium Is Under-recognized and Underestimated Following TAVR, Putting Patients in Peril

Shelley Wood

January 20, 2016

News Daily News

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Michael O'Riordan

January 18, 2016

Presentation

A-fib Associated With Increased Mortality in Patients Undergoing TAVR: PARTNER Analysis

Presenter: Angelo Biviano

January 07, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Yael L. Maxwell

November 24, 2015

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Daily News

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Yael L. Maxwell

August 30, 2015

Presentation

Baseline Characteristics and Prognostic Implications of Preexisting and New-Onset A-fib After TAVR

Presenter: R. Chopard

August 27, 2015

News Daily News

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

August 25, 2015

News Daily News

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

August 20, 2015

News Daily News

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

Yael L. Maxwell

August 05, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

Advertisement

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

Delirium Is Under-recognized and Underestimated Following TAVR, Putting Patients in Peril

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

A-fib Associated With Increased Mortality in Patients Undergoing TAVR: PARTNER Analysis

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Boston Scientific Announces Scheduled Presentations At TCT 2015

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Baseline Characteristics and Prognostic Implications of Preexisting and New-Onset A-fib After TAVR

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content